Valuation: Dechra Pharmaceuticals

Market Cap 4.4B 5.88B 5.14B 4.72B 8.35B 560B 8.48B 56.72B 22.05B 275B 22.07B 21.6B 948B P/E 2022
64.8x
P/E 2023 -150x
Enterprise Value 4.83B 6.45B 5.64B 5.19B 9.17B 615B 9.31B 62.26B 24.2B 302B 24.23B 23.71B 1,041B EV / Sales 2022
5.8x
EV / Sales 2023 6.08x
Free-Float
-
Yield 2022
1.3%
Yield 2023 0.34%
3 years 3,644
Extreme 3644
4,145.84
5 years 2,473.32
Extreme 2473.323
5,525
10 years 1,119
Extreme 1119
5,525
Manager TitleAgeSince
Chief Executive Officer - 09/06/2024
Director of Finance/CFO 46 02/04/2019
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 46 29/10/2019
Director/Board Member 68 30/11/2016
Director/Board Member 59 31/01/2019
Date Insider Type Main position Quantity % Market Cap.
14/01/24Free

Chief Financial Officer

2,335 0.0021%
14/01/24Free

Chief Financial Officer

8,600 0.0076%
14/01/24Free

Chief Financial Officer

9,983 0.0088%

Financials

2022 2023
Net sales 682M 910M 796M 731M 1.29B 86.69B 1.31B 8.78B 3.41B 42.61B 3.42B 3.34B 147B 762M 1.02B 889M 817M 1.44B 96.82B 1.47B 9.81B 3.81B 47.59B 3.82B 3.74B 164B
Net income 58.2M 77.72M 67.94M 62.44M 110M 7.4B 112M 750M 291M 3.64B 292M 285M 12.53B -27.9M -37.26M -32.57M -29.93M -52.92M -3.55B -53.72M -359M -140M -1.74B -140M -137M -6.01B
Net Debt 208M 278M 243M 223M 395M 26.47B 401M 2.68B 1.04B 13.01B 1.04B 1.02B 44.84B 430M 574M 502M 461M 816M 54.69B 828M 5.54B 2.15B 26.88B 2.16B 2.11B 92.63B
Logo Dechra Pharmaceuticals
Dechra Pharmaceuticals PLC specializes in the manufacturing and marketing of veterinary pharmaceutical products. Net sales break down by family of products as follows: - companion animal products (74.6%); - food producing animal products (11.5%); - equine health products (7.3%); - animal feeds (5.1%); - other (1.5%): products manufactured by third parties. Net sales are distributed geographically as follows: the United Kingdom (8.5%), Germany (9.2%), Europe (31.2%), the United States (37.9%) and other (13.2%).
Employees
-
Sector
-